Injectable Hydrogels for Ophthalmic Applications

Overview

Journal J Control Release

Specialty Pharmacology

Date 2017 Oct 25

PMID 29061512

Citations 33

Authors

Kai Wang

Zongchao Han

Affiliations

Soon will be listed here.

Abstract

The demand for effective eye therapies is driving the development of injectable hydrogels as new medical devices for controlled delivery and filling purposes. This article introduces the properties of injectable hydrogels and summarizes their versatile application in the treatment of ophthalmic diseases, including age-related macular degeneration, cataracts, diabetic retinopathy, glaucoma, and intraocular cancers. A number of injectable hydrogels are approved by FDA as surgery sealants, tissue adhesives, and are now being investigated as a vitreous humor substitute. Research on hydrogels for drug, factor, nanoparticle, and stem cell delivery is still under pre-clinical investigation or in clinical trials. Although substantial progress has been achieved using injectable hydrogels, some challenging issues must still be overcome before they can be effectively used in medical practice.

Citing Articles

Development of self-healing hydrogels to support choroidal endothelial cell transplantation for the treatment of early age related macular degeneration.

Pandala N, Pandala N, Han I, Han I, Renze L, Renze L Acta Biomater. 2024; 194:98-108.

PMID: 39710218 PMC: 11867867. DOI: 10.1016/j.actbio.2024.12.052.

Hyaluronic Acid-Based Dynamic Hydrogels for Cartilage Repair and Regeneration.

Zhang M, Ye Q, Zhu Z, Shi S, Xu C, Xie R Gels. 2024; 10(11).

PMID: 39590059 PMC: 11594165. DOI: 10.3390/gels10110703.

Fabrication of injectable, adhesive, self-healing, superabsorbent hydrogels based on quaternary ammonium chitosan and oxidized pullulan.

He Q, Ding X, Deng J, Zhang Y, Wang X, Zhan D Heliyon. 2024; 10(19):e38577.

PMID: 39435091 PMC: 11491910. DOI: 10.1016/j.heliyon.2024.e38577.

Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.

Wykoff C, Kuppermann B, Regillo C, Chang M, Hariprasad S, Duker J J Vitreoretin Dis. 2024; 8(5):577-586.

PMID: 39318989 PMC: 11418737. DOI: 10.1177/24741264241267065.

Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges.

Wu K, Akbar D, Giunta M, Kalevar A, Tran S Materials (Basel). 2024; 17(1).

PMID: 38203940 PMC: 10780040. DOI: 10.3390/ma17010086.

References

Chien Y, Liao Y, Liu D, Lin H, Chen S, Chen H . Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel. Biomaterials. 2012; 33(32):8003-16. DOI: 10.1016/j.biomaterials.2012.07.029. View

Van Vlierberghe S, Dubruel P, Schacht E . Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review. Biomacromolecules. 2011; 12(5):1387-408. DOI: 10.1021/bm200083n. View

Shibata H, Heo Y, Okitsu T, Matsunaga Y, Kawanishi T, Takeuchi S . Injectable hydrogel microbeads for fluorescence-based in vivo continuous glucose monitoring. Proc Natl Acad Sci U S A. 2010; 107(42):17894-8. PMC: 2964191. DOI: 10.1073/pnas.1006911107. View

Ballios B, Cooke M, Donaldson L, Coles B, Morshead C, van der Kooy D . A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation. Stem Cell Reports. 2015; 4(6):1031-45. PMC: 4471829. DOI: 10.1016/j.stemcr.2015.04.008. View

Mitra R, Gao R, Zheng M, Wu M, Voinov M, Smirnov A . Glycol Chitosan Engineered Autoregenerative Antioxidant Significantly Attenuates Pathological Damages in Models of Age-Related Macular Degeneration. ACS Nano. 2017; 11(5):4669-4685. DOI: 10.1021/acsnano.7b00429. View

Han Z, Banworth M, Makkia R, Conley S, Al-Ubaidi M, Cooper M . Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. FASEB J. 2015; 29(6):2535-44. PMC: 4447225. DOI: 10.1096/fj.15-270363. View

Rosenfeld P, Brown D, Heier J, Boyer D, Kaiser P, Chung C . Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14):1419-31. DOI: 10.1056/NEJMoa054481. View

Pakulska M, Ballios B, Shoichet M . Injectable hydrogels for central nervous system therapy. Biomed Mater. 2012; 7(2):024101. DOI: 10.1088/1748-6041/7/2/024101. View

Tan H, Chu C, Payne K, Marra K . Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials. 2009; 30(13):2499-506. PMC: 2676686. DOI: 10.1016/j.biomaterials.2008.12.080. View

10.

Sakiyama-Elbert S . Incorporation of heparin into biomaterials. Acta Biomater. 2013; 10(4):1581-7. PMC: 3949739. DOI: 10.1016/j.actbio.2013.08.045. View

11.

Mitra R, Zheng M, Han Z . Nanoparticle-motivated gene delivery for ophthalmic application. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 8(1):160-74. PMC: 4688250. DOI: 10.1002/wnan.1356. View

12.

Lai J . Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use. J Mater Sci Mater Med. 2010; 21(6):1899-911. DOI: 10.1007/s10856-010-4035-3. View

13.

Hoffman A . Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 54(1):3-12. DOI: 10.1016/s0169-409x(01)00239-3. View

14.

Bennett J, Wellman J, Marshall K, McCague S, Ashtari M, DiStefano-Pappas J . Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016; 388(10045):661-72. PMC: 5351775. DOI: 10.1016/S0140-6736(16)30371-3. View

15.

Bhattarai N, Gunn J, Zhang M . Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev. 2009; 62(1):83-99. DOI: 10.1016/j.addr.2009.07.019. View

16.

Zhao Z, Chen Y, Wang J, Sternberg P, Freeman M, Grossniklaus H . Age-related retinopathy in NRF2-deficient mice. PLoS One. 2011; 6(4):e19456. PMC: 3084871. DOI: 10.1371/journal.pone.0019456. View

17.

de Groot J, van Beijma F, Haitjema H, Dillingham K, HODD K, Koopmans S . Injectable intraocular lens materials based upon hydrogels. Biomacromolecules. 2001; 2(3):628-34. DOI: 10.1021/bm005622r. View

18.

Fitzpatrick S, Mazumder M, Lasowski F, Fitzpatrick L, Sheardown H . PNIPAAm-grafted-collagen as an injectable, in situ gelling, bioactive cell delivery scaffold. Biomacromolecules. 2010; 11(9):2261-7. DOI: 10.1021/bm100299j. View

19.

Caprioli J, Coleman A . Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010; 149(5):704-12. DOI: 10.1016/j.ajo.2010.01.018. View

20.

Wollensak G, Spoerl E, Seiler T . Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135(5):620-7. DOI: 10.1016/s0002-9394(02)02220-1. View